P1190: EFFICACY AND SAFETY OF SELINEXOR COMBINING WITH R-CHOP IN THE TREATMENT OF NEWLY DIAGNOSED HIGH RISK (IPI 3-5) GCB SUBTYPE DLBCL PATIENTS: A MULTICENTER RETROSPECTIVE REAL-WORLD STUDY FROM CHINA.
LI Zhi-Ming,
Hang Yang,
Yanxue Yin,
Yajun LI,
Shiyong Zhou,
Peng Sun,
Yu Wang,
Lu Zhang,
Hui Zhou,
Huilai Zhang
Affiliations
LI Zhi-Ming
1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China
Hang Yang
1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China
Yanxue Yin
2 Huazhong University Science and Technology Tongji Medical College Affiliated Union Hospital State Administration of Traditional Chinese Medicine Traditional Chi, Hematology, Wu Han
Yajun LI
3 Hunan Cancer Hospital, Lymphoma & Hematology Department, Changsha, China
Shiyong Zhou
4 Tianjin Medical University Cancer Institute and Hospital, Department of Lymphoma, Tianjin, China
Peng Sun
1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China
Yu Wang
1 Dongfeng East Road, Internal medicine, Guang Zhou Shi, China
Lu Zhang
2 Huazhong University Science and Technology Tongji Medical College Affiliated Union Hospital State Administration of Traditional Chinese Medicine Traditional Chi, Hematology, Wu Han
Hui Zhou
3 Hunan Cancer Hospital, Lymphoma & Hematology Department, Changsha, China
Huilai Zhang
4 Tianjin Medical University Cancer Institute and Hospital, Department of Lymphoma, Tianjin, China
